We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Europe open: Shares slip amid AI threat worries, Novo Nordisk outlook

Wed 04 February 2026 07:59 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Market latest

FTSE 100 | FTSE 250 | Paris CAC 40 | Dow Jones | NASDAQ

10455.43 | Positive 140.84 (1.37%)
Graph

Prices delayed by at least 15 minutes

(Sharecast News) - European stocks edged lower at the open on Wednesday as investors digested the latest earnings dump and the threat to software stocks from the expanding tentacles of artificial intelligence which sparked a sell-off on the Continent and spread to the US overnight.

The pan-regional Stoxx 600 index was down 0.06% to 617 at 0833 GMT. Germany's DAX was 0.03% lower, while the UK's FTSE 100 outperformed with a 0.59% rise as an improved takeover offer by Zurich for rival insurer Beazley drive the index to a new record high of 10,383 points.

Beazley shares also touched a new peak of 12.63 each, a rise of more than 8%.

Concerns about AI's spread sparked a sell-off in the US overnight after an updated chatbot release from AI developer Anthropic designed to automate legal work such as contract reviewing and templated responses.

"The announcement spooked markets, triggering a sharp selloff in software companies that sell data analytics and decision-making tools to lawyers, banks and corporates, on fears that AI and new players are coming for their lunch - and at an accelerated pace," said Swissquote Bank analyst Ipek Ozkardeskaya.

Precious metal prices stabilised after days of geopolitical volatility. Gold gained 2.84% to sit above the $5,000 mark, while silver climbed almost 3% to $90 an ounce.

In equity news, shares in Novo Nordisk plunged by almost a fifth after the company released its results ahead of schedule overnight.

The drug maker warned investors that sales and profit growth would fall this year, after it was hit by lower prices in the US and the end of exclusivity for its Wegovy and Ozempic weight loss drugs in China, Brazil and Canada.

UBS fell after the Swiss lender despite fourth-quarter net profits beating forecasts.

Spanish bank Santander was also lower after announcing the purchase of US regional lender Webster Bank in a deal worth $12.2bn.

Reporting by Frank Prenesti for Sharecast.com

    Daily market update emails

    • FTSE 100 riser and faller updates
    • Breaking market news, plus the latest share research, tips and broker comments

    Register now for free market updates

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More stock market reports from ShareCast

    Latest economy and stock market articles